Det kan anbefales, at levodopadosis reduceres både under dosisstigning og vedligeholdelsesbehandling med Sifrol, afhængigt af den enkelte patients reaktioner.
It is recommended that the dosage of levodopa is reduced during both the dose escalation and the maintenance treatment with SIFROL, depending on reactions in individual patients.